Cargando…
Memantine administration prevented chorea movement in Huntington’s disease: a case report
BACKGROUND: Huntington’s disease is an autosomal dominant inherited disorder characterized by personality changes (such as irritability and restlessness) and psychotic symptoms (such as hallucinations and delusions). When the personality changes become noticeable, involuntary movements (chorea) also...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578007/ https://www.ncbi.nlm.nih.gov/pubmed/37840138 http://dx.doi.org/10.1186/s13256-023-04161-z |
_version_ | 1785121432088346624 |
---|---|
author | Saigoh, Kazumasa Hirano, Makito Mitsui, Yoshiyuki Oda, Itsuki Ikegawa, Atsuko Samukawa, Makoto Yoshikawa, Keisuke Yamagishi, Yuko Kusunoki, Susumu Nagai, Yoshitaka |
author_facet | Saigoh, Kazumasa Hirano, Makito Mitsui, Yoshiyuki Oda, Itsuki Ikegawa, Atsuko Samukawa, Makoto Yoshikawa, Keisuke Yamagishi, Yuko Kusunoki, Susumu Nagai, Yoshitaka |
author_sort | Saigoh, Kazumasa |
collection | PubMed |
description | BACKGROUND: Huntington’s disease is an autosomal dominant inherited disorder characterized by personality changes (such as irritability and restlessness) and psychotic symptoms (such as hallucinations and delusions). When the personality changes become noticeable, involuntary movements (chorea) also develop. The disease is caused by the CAG repeat expansion in the coding region of the HTT gene, and the diagnosis is based on the presence of this expansion. However, there is currently no effective treatment for the progression of Huntington’s disease and its involuntary motor symptoms. Herein, we present a case in which memantine was effective in treating the chorea movements of Huntington’s disease. CASE PRESENTATION: A 75-year-old Japanese woman presented to the hospital with involuntary movements of Huntington’s disease that began when she was 73 years old. In a cerebral blood flow test (N-isopropyl-p-iodoamphetamine–single-photon emission computed tomography), decreased blood flow was observed in the precuneus (anterior wedge) and posterior cingulate gyrus. Usually, such areas of decreased blood flow are observed in patients with Alzheimer’s-type dementia. So, we administered memantine for Alzheimer’s-type dementia, and this treatment suppressed the involuntary movements of Huntington’s disease, and the symptoms progressed slowly for 7 years after the onset of senility. In contrast, her brother died of complications of pneumonia during the course of Huntington’s disease. CONCLUSIONS: We recorded changes in parameters such as the results of the N-isopropyl-p-iodoamphetamine–single-photon emission computed tomography and gait videos over 7 years. Treatment with memantine prevented the chorea movement and the progression of Huntington’s disease. We believe this record will provide clinicians with valuable information in diagnosing and treating Huntington’s disease. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13256-023-04161-z. |
format | Online Article Text |
id | pubmed-10578007 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-105780072023-10-17 Memantine administration prevented chorea movement in Huntington’s disease: a case report Saigoh, Kazumasa Hirano, Makito Mitsui, Yoshiyuki Oda, Itsuki Ikegawa, Atsuko Samukawa, Makoto Yoshikawa, Keisuke Yamagishi, Yuko Kusunoki, Susumu Nagai, Yoshitaka J Med Case Rep Case Report BACKGROUND: Huntington’s disease is an autosomal dominant inherited disorder characterized by personality changes (such as irritability and restlessness) and psychotic symptoms (such as hallucinations and delusions). When the personality changes become noticeable, involuntary movements (chorea) also develop. The disease is caused by the CAG repeat expansion in the coding region of the HTT gene, and the diagnosis is based on the presence of this expansion. However, there is currently no effective treatment for the progression of Huntington’s disease and its involuntary motor symptoms. Herein, we present a case in which memantine was effective in treating the chorea movements of Huntington’s disease. CASE PRESENTATION: A 75-year-old Japanese woman presented to the hospital with involuntary movements of Huntington’s disease that began when she was 73 years old. In a cerebral blood flow test (N-isopropyl-p-iodoamphetamine–single-photon emission computed tomography), decreased blood flow was observed in the precuneus (anterior wedge) and posterior cingulate gyrus. Usually, such areas of decreased blood flow are observed in patients with Alzheimer’s-type dementia. So, we administered memantine for Alzheimer’s-type dementia, and this treatment suppressed the involuntary movements of Huntington’s disease, and the symptoms progressed slowly for 7 years after the onset of senility. In contrast, her brother died of complications of pneumonia during the course of Huntington’s disease. CONCLUSIONS: We recorded changes in parameters such as the results of the N-isopropyl-p-iodoamphetamine–single-photon emission computed tomography and gait videos over 7 years. Treatment with memantine prevented the chorea movement and the progression of Huntington’s disease. We believe this record will provide clinicians with valuable information in diagnosing and treating Huntington’s disease. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13256-023-04161-z. BioMed Central 2023-10-16 /pmc/articles/PMC10578007/ /pubmed/37840138 http://dx.doi.org/10.1186/s13256-023-04161-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Case Report Saigoh, Kazumasa Hirano, Makito Mitsui, Yoshiyuki Oda, Itsuki Ikegawa, Atsuko Samukawa, Makoto Yoshikawa, Keisuke Yamagishi, Yuko Kusunoki, Susumu Nagai, Yoshitaka Memantine administration prevented chorea movement in Huntington’s disease: a case report |
title | Memantine administration prevented chorea movement in Huntington’s disease: a case report |
title_full | Memantine administration prevented chorea movement in Huntington’s disease: a case report |
title_fullStr | Memantine administration prevented chorea movement in Huntington’s disease: a case report |
title_full_unstemmed | Memantine administration prevented chorea movement in Huntington’s disease: a case report |
title_short | Memantine administration prevented chorea movement in Huntington’s disease: a case report |
title_sort | memantine administration prevented chorea movement in huntington’s disease: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578007/ https://www.ncbi.nlm.nih.gov/pubmed/37840138 http://dx.doi.org/10.1186/s13256-023-04161-z |
work_keys_str_mv | AT saigohkazumasa memantineadministrationpreventedchoreamovementinhuntingtonsdiseaseacasereport AT hiranomakito memantineadministrationpreventedchoreamovementinhuntingtonsdiseaseacasereport AT mitsuiyoshiyuki memantineadministrationpreventedchoreamovementinhuntingtonsdiseaseacasereport AT odaitsuki memantineadministrationpreventedchoreamovementinhuntingtonsdiseaseacasereport AT ikegawaatsuko memantineadministrationpreventedchoreamovementinhuntingtonsdiseaseacasereport AT samukawamakoto memantineadministrationpreventedchoreamovementinhuntingtonsdiseaseacasereport AT yoshikawakeisuke memantineadministrationpreventedchoreamovementinhuntingtonsdiseaseacasereport AT yamagishiyuko memantineadministrationpreventedchoreamovementinhuntingtonsdiseaseacasereport AT kusunokisusumu memantineadministrationpreventedchoreamovementinhuntingtonsdiseaseacasereport AT nagaiyoshitaka memantineadministrationpreventedchoreamovementinhuntingtonsdiseaseacasereport |